Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Lab-grown skin layer could replace animal testing
Scientists have developed the first ever lab grown epidermis.
Skin model could help develop treatments for skin conditions

Scientists have developed the first ever lab-grown skin layer. It could replace animal testing for drugs and cosmetics, as well as helping to develop new treatments for skin disorders.

The skin layer has been grown from human stem cells. It is the first lab-grown epidermis with the functional permeability barrier needed for drug testing.

Leading the research team from Kings College London, Dr Dusko Ilic said their new method could be scaled up for commercial testing of drugs and cosmetics.

Scientists used human stem cells to create an unlimited supply of pure keratinocytes - the main cell type in the epidermis.

These were used to produce 3D epidermal equivalents in a high-to-low humidity environment to build the functional barrier for protecting the body from losing moisture and preventing entry of chemicals, toxins and microbes.

The study, which has been published in the journal Stem Cell Reports, was carried out in collaboration with the San Francisco Veteran Affairs Medical Center (SFVAMC).

Scientists say the model can be used to study conditions such as ichthyosis (dry, flaky skin) and atopic dermatitis, where the skin's barrier is defective.

Dr Theodora Mauro, leader of the SFVAMC team says: "We can use the model to study how the skin barrier develops normally, how the barrier is impaired in different diseases and how we can stimulate its repair and recovery."

Furthermore, Dr Ilic says the model could be tailored to study particular skin conditions and sensitivities in different populations, by growing epidermal equivalents representing different types of skin.

Become a member or log in to add this story to your CPD history

RUMA CA&E extends survey deadline

News Story 1
 RUMA CA&E has extended the deadline for its online survey into vaccine availability.

Vets, SQPs, retailers and wholesalers will now have until Friday, 26 September at 5pm to submit their response.

The survey aims to further understanding into the vaccine supply challenges faced by the sector. It will also consider the short and long term impacts of disruption issues.

Insights are anonymous, and will be shared with industry stakeholders and government bodies.

The survey can be accessed here

Click here for more...
News Shorts
Dechra launches checklist for veterinary sustainability

Global animal health specialist Dechra has announced the world's first Veterinary Green Theatre Checklist (VGTC) to help make surgery more sustainable.

Endorsed by leading veterinary organisations, including the BEVA, BVNA and RCVS Knowledge, the checklist is designed to reduce the environmental footprint of veterinary care, while supporting better animal health outcomes.

The checklist was launched at the World Congress of Veterinary Anaesthesia and Analgesia in Paris and will be followed by an internal training and awareness campaign. For more information, visit dechra.com